Liu, X., Munro, A., Wright, A., Feng, S., Janani, L., Aley, P., Babbage, G., Baker, J., Baxter, D., Bawa, T., Bula, M., Cathie, K., Chatterjee, K., Dodd, K., Enever, Y., Fox, L., Qureshi, E., Goodman, A., Green, C., Haughney, J., Hicks, A., Jones, C., Kanji, N., van der Klaauw, A., Libri, V., Llewelyn, M., Mansfield, R., Maallah, M., McGregor, A., Minassian, A., Moore, P., Mughal, M., Mujadidi, Y., Belhadef, H., Holliday, K., Osanlou, O., Osanlou, R., Owens, D., Pacurar, M., Palfreeman, A., Pan, D., Rampling, T., Regan, K., Saich, S., Saralaya, D., Sharma, S., Sheridan, R., Stokes, M., Thomson, E., Todd, S., Twelves, C., Read, R., Charlton, S., Hallis, B., Ramsay, M., Andrews, N., Lambe, T., Nguyen-Van-Tam, J., Cornelius, V., Snape, M. & Faust, S. 2023, 'Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial', Journal of infection. http://dx.doi.org/10.1016/j.jinf.2023.04.012